UTAH MEDICAL PRODUCTS, INC. Other Non-Current Liabilities
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Other Non-Current Liabilities of $0 as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2025-03-26
- 2024-12-31: Other Liabilities, Noncurrent $0.00.
- 2024-09-30: Other Liabilities, Noncurrent $698.00K.
- 2024-06-30: Other Liabilities, Noncurrent $698.00K.
- 2024-03-31: Other Liabilities, Noncurrent $698.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-26 | |
| 2024-09-30 | $698.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $698.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $698.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $698.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.26M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $1.26M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.26M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $1.68M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.68M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.95M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.68M 10-Q · filed 2022-11-10 | |
| 2021-09-30 | $2.20M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.83M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $2.07M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $2.00M 10-Q · filed 2021-11-12 | $2.15M 10-Q · filed 2021-05-11 |
| 2020-09-30 | $2.13M 10-Q/A · filed 2020-11-09 | |
| 2020-06-30 | $2.13M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $2.01M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $2.24M 10-Q/A · filed 2020-11-09 | |
| 2019-09-30 | $2.44M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.44M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.50M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.44M 10-Q · filed 2019-11-07 | $2.54M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $2.44M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $5.17M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $3.11M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $5.79M 10-Q · filed 2018-11-07 | $3.10M 10-Q · filed 2018-05-09 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-12 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-12 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $339.00K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $363.00K 10-K · filed 2014-03-12 | |
| 2012-09-30 | $459.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $495.00K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $505.00K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $522.00K 10-K · filed 2013-03-07 | |
| 2011-09-30 | $460.00K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $592.00K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |